Madden Martin J.
SEC CIK 1696864 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NVCR | NovoCure Ltd | Dir | 30.3K | — | $22.4K | 4 | 2021-08-05 | 2026-06-03 |
Most active insiders at NVCR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DOYLE WILLIAM F | Executive COB, Dir | — | $933.1K |
| 2 | Leonard Frank X | EVP, Pres, Novocure Oncology | — | $919.8K |
| 3 | Paravasthu Mukund | COO | — | $693.8K |
| 4 | Weinberg Uri | Chf Medical, Innovation Ofr | — | $232.2K |
| 5 | Brackmann Christoph | CFO | — | $85.3K |
| 6 | Stafford Kristin | Dir | — | $46.4K |
| 7 | Ocean Allyson J | Dir | — | $46.4K |
| 8 | Scannell Timothy J | Dir | — | $46.4K |
| 9 | VERNON W ANTHONY | Dir | — | $46.4K |
| 10 | Hung David | Dir | — | $46.4K |
| 17 | Madden Martin J. | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-05 16:26 | 2026-06-03 | NVCR | NovoCure Ltd | Madden Martin J. | Dir | A - Grant | $0.00 | +11.6K | 30.3K | +62% | $0 |
| 2025-06-04 | 2025-06-03 | NVCR | NovoCure Ltd | Madden Martin J. | Dir | S - Sale | $17.19 | -999 | 18.7K | -5% | -$17.2K | |
| D | 2024-06-06 | 2024-06-05 | NVCR | NovoCure Ltd | Madden Martin J. | Dir | A - Grant | $0.00 | +4,053 | 19.7K | +26% | $0 |
| I | 2021-08-06 | 2021-08-05 | NVCR | NovoCure Ltd | Madden Martin J. | Dir | S - Sale | $153.13 | -34 | 384 | -8% | -$5,206 |
Purchase Sale Sale after option exercise All abbreviations